on 08 Nov 2022
Last Applicant/ Owned by
1 Deerpark Drive, Suite R
Monmouth Junction
NJ
08852
Serial Number
88365991 filed on 01st Apr 2019
Registration Number
6895554 registered on 08th Nov 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neuroRead More
Assays for research purposes; Biological and chemical reagents used for non-medical research and laboratory purposes, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; Biological and chemical test kits comprised of biological, chemical, or diagnostic reagents for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, for laboratory and research use
01st Sep 2022
01st Sep 2022
Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes; Biological and chemical test kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for testing of bodily fluids and substances extracted from bodily fluids, namely, cells, proteins, small molecules, nucleotides, and nucleic acids for use in disease detection, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases
01st Sep 2022
01st Sep 2022
Medical diagnostic apparatus for testing cells, tissue, biomolecules, proteins, small molecules, and nucleotides; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, medical apparatus for diagnostic testing of health conditions, diseases, or abnormalities, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and endocrine diseases, and other tissue-based diagnostic testing, cytology, and cell based testing; Medical apparatus, devices, and instruments for wellness testing, health condition testing, and healthcare testing, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical apparatus, devices, and instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample, in the nature of apparatus for DNA and RNA testing for medical purposes
01st Sep 2022
01st Sep 2022
Scientific laboratory services, namely, detection and identification of cells, proteins, small molecules, and nucleotides in a sample for scientific, research, and technological purposes; Medical laboratory services, namely, providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of infectious and residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; Development of new technology for others in the fields of biotechnology, DNA, RNA, small molecules, proteins, and nucleotide analysis services for scientific research purposes; Providing medical and scientific research information in the field of clinical trials, assays and assay development, diagnostics, cancer, RNA, DNA, small molecules, proteins, and nucleotides; Research and development in the medical and digital diagnostics and biotechnology fields; Custom design and development of chemical reagents and biochemical assays; Laboratory research in the field of oncology, hematology, and infectious diseases
01st Sep 2022
01st Sep 2022
Medical services; Medical assistance; Medical consultations; Medical counseling; Medical information; Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing in the nature of the diagnosis of diseases, namely, cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases, diagnostic testing, namely, medical testing for diagnostic purposes, and wellness services, namely, providing wellness information in the fields of health and wellness, all of the foregoing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample in the nature of medical testing for diagnostic or treatment purposes
01st Sep 2022
01st Sep 2022
No 88365991
No Service Mark
No ESX-T106
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 08th Nov 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 08th Nov 2022 | REGISTERED-PRINCIPAL REGISTER |
| 01st Oct 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 30th Sep 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 23rd Sep 2022 | STATEMENT OF USE PROCESSING COMPLETE |
| 23rd Sep 2022 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 12th Sep 2022 | USE AMENDMENT FILED |
| 12th Sep 2022 | TEAS STATEMENT OF USE RECEIVED |
| 12th Mar 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 10th Mar 2022 | SOU EXTENSION 4 GRANTED |
